Publication of exemption document in relation to the proposed combination of Novozymes and Chr. Hansen, confirmation of outlook for 2023 and proposed candidates to the Board of Directors of the combined company
Please read the full announcement in the attached PDF Attachment 2023_39_Exemption_Document_and_NewCo_Board_Composition